Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infection With HIV Co-Infection”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Post-approval studies (Phase 4)Study completedNCT03098121
What this trial is testing

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

Who this might be right for
Chronic Hepatitis C
Taoyuan General Hospital 40
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Large-scale testing (Phase 3)Study completedNCT02103439
What this trial is testing

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Who this might be right for
HepatitisHepatitis CHepatitis C/ Human Immunodeficiency Virus Coinfection
Biocad 140
Large-scale testing (Phase 3)Study completedNCT01667731
What this trial is testing

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 224
Not applicableEnded earlyNCT01040039
What this trial is testing

Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV

Who this might be right for
HIV InfectionsHepatitis C Virus
Rockefeller University 20
Testing effectiveness (Phase 2)Study completedNCT00959699
What this trial is testing

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Who this might be right for
HIV InfectionsHepatitis CHCV Infection
Merck Sharp & Dohme LLC 99
Large-scale testing (Phase 3)Study completedNCT02006745
What this trial is testing

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

Who this might be right for
HIV
St Stephens Aids Trust 20
Testing effectiveness (Phase 2)Study completedNCT01707472
What this trial is testing

Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

Who this might be right for
Liver FibrosisHepatitis CHIV+1 more
Gilead Sciences 18
Large-scale testing (Phase 3)Study completedNCT03222583
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 546
Large-scale testing (Phase 3)Ended earlyNCT01718301
What this trial is testing

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Who this might be right for
Hepatitis CHIV InfectionsCOINFECTION
Anna Cruceta 108
Not applicableEnrolling By InvitationNCT02699736
What this trial is testing

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Who this might be right for
HIVHepatitis BHepatitis C+10 more
Rigshospitalet, Denmark 23,000
Post-approval studies (Phase 4)WithdrawnNCT01225705
What this trial is testing

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

Who this might be right for
HIVHepatitis C
University Hospital, Bonn
Not applicableUnknownNCT02102451
What this trial is testing

Control and Elimination Within Australia of Hepatitis C From People Living With HIV

Who this might be right for
Hepatitis CHIVHIV-HCV Coinfection
Kirby Institute 492
Testing effectiveness (Phase 2)Study completedNCT00983853
What this trial is testing

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Who this might be right for
Hepatitis CHIV Infections
Vertex Pharmaceuticals Incorporated 62
Large-scale testing (Phase 3)Study completedNCT02634008
What this trial is testing

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

Who this might be right for
Hepatitis C, Acute
Kirby Institute 83
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Post-approval studies (Phase 4)Study completedNCT00358696
What this trial is testing

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Who this might be right for
HIVHIV Infections
University of British Columbia 30
Large-scale testing (Phase 3)Study completedNCT01479868
What this trial is testing

Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Who this might be right for
Hepatitis C Virus Genotype-1
Janssen R&D Ireland 109
Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Next Page